Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 234 (RNA5SP234) is classified as a pseudogene related to the 5S ribosomal RNA gene family[1][2]. Pseudogenes like RNA5SP234 represent genomic DNA sequences similar to known genes, but typically lack the capacity to encode functional RNA or protein due to mutations or genetic alterations disrupting normal gene expression[1][2]. There is currently no evidence that RNA5SP234 is transcribed into a functional RNA, nor does it encode a protein or play a direct biological role. Unlike functional 5S ribosomal RNA, which folds into a conserved secondary structure and participates in the assembly and function of the ribosome[3][5], RNA5SP234 does not contribute to ribosomal assembly or function. It is not considered a therapeutic target, and there are no known drugs, biomarkers, disease associations, or established clinical relevance for this pseudogene[1][2]. The entry's relevance is primarily for genomic annotation and evolutionary studies of gene families rather than for disease, pharmacology, or biomarker applications. Notes: - RNA5SP234 is a processed pseudogene, meaning it originated from a reverse-transcribed RNA product inserted back into the genome, and not from gene duplication or rearrangement that retains function[1][2]. - While other pseudogenes can occasionally influence gene regulation or serve as disease biomarkers[4], there is no published evidence for any such role for RNA5SP234 specifically. - The entry may be considered "incorrect" in a therapeutic/biological targeting context because it is not a functional gene, receptor, or target, but rather a non-functional genomic sequence[1][2].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 234 (RNA5SP234).